Methodological insights from the EPISTOP trial to designing clinical trials in rare diseases-A secondary analysis of a randomized clinical trial.
<h4>Background</h4>In clinical research, the most appropriate way to assess the effect of an intervention is to conduct a randomized controlled trial (RCT). In the field of rare diseases, conducting an RCT is challenging, resulting in a low rate of clinical trials, with a high frequency...
Saved in:
| Main Authors: | Stephanie Wied, Ralf-Dieter Hilgers, Nicole Heussen, Katarzyna Kotulska, Maya Dirani, Mathieu Kuchenbuch, Sergiusz Jozwiak, Rima Nabbout |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2024-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0312936 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Randomization in clinical trials with small sample sizes using group sequential designs
by: Daniel Bodden, et al.
Published: (2025-01-01) -
Randomization in clinical trials with small sample sizes using group sequential designs.
by: Daniel Bodden, et al.
Published: (2025-01-01) -
METHODOLOGICAL ISSUES OF CLINICAL TRIALS IN THE PEDIATRIC POPULATION
by: S.V. Topolyanskaya
Published: (2010-09-01) -
Reflection on clinical and methodological issues in rare disease clinical trials.
by: Johan Verbeeck, et al.
Published: (2025-06-01) -
Methodology and Application of Adaptive and Sequential Approaches in Contemporary Clinical Trials
by: Zhengjia Chen, et al.
Published: (2012-01-01)